NeuroOne Medical Technologies Corporation Other Selling, General and Administrative Expense
NeuroOne Medical Technologies Corporation (NMTC) reported Other Selling, General and Administrative Expense of $280.52 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2024-05-14
- NeuroOne Medical Technologies Corporation other selling, general and administrative expense for the quarter ending 2024-03-31 was $280.52K, a 40.63% increase year-over-year.
- NeuroOne Medical Technologies Corporation other selling, general and administrative expense for the quarter ending 2023-09-30 was $213.17K, a 0.80% increase year-over-year.
- NeuroOne Medical Technologies Corporation other selling, general and administrative expense for the quarter ending 2023-06-30 was $237.01K, a 12.07% increase year-over-year.
- NeuroOne Medical Technologies Corporation other selling, general and administrative expense for the quarter ending 2023-03-31 was $199.47K, a 2.36% increase year-over-year.
- NeuroOne Medical Technologies Corporation other selling, general and administrative expense for fiscal 2023 was $905.11K, a 15.92% increase from fiscal 2022.
- NeuroOne Medical Technologies Corporation other selling, general and administrative expense for fiscal 2022 was $780.82K.
| Period end | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 6 month | Other Selling, General and Administrative Expense 9 month | Other Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $280.52K 10-Q · filed 2024-05-14 | $523.71K 10-Q · filed 2024-05-14 | ||
| 2023-09-30 | $213.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $450.18K derived: sum of 2 quarters · filed 2023-12-15 | $649.64K derived: sum of 3 quarters · filed 2024-05-14 | $905.11K 10-K · filed 2023-12-15 |
| 2023-06-30 | $237.01K 10-Q · filed 2023-08-14 | $436.47K derived: sum of 2 quarters · filed 2024-05-14 | $691.94K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $199.47K 10-Q · filed 2024-05-14 | $454.93K 10-Q · filed 2024-05-14 | ||
| 2022-09-30 | $211.47K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | $422.94K derived: sum of 2 quarters · filed 2023-12-15 | $617.82K derived: sum of 3 quarters · filed 2023-12-15 | $780.82K 10-K · filed 2023-12-15 |
| 2022-06-30 | $211.47K 10-Q · filed 2023-08-14 | $406.35K derived: sum of 2 quarters · filed 2023-08-14 | $569.35K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $194.87K 10-Q · filed 2023-05-12 | $357.88K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |